Listar por autor "Carrión, J.A."
Mostrando ítems 1-5 de 5
-
Effectiveness and safety of sofosbuvir‐based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis: results of a multicenter real‐life cohort
Alonso, S.; Riveiro-Barciela, M.; Fernández, I.; Rincón, D.; Real, Y.; Llerena, S.; Gea, F.; Olveira, A.; Fernández-Carrillo, C.; Polo, B.; Carrión, J.A.; Gómez, A.; Devesa, M.J.; Baliellas, C.; Castro-Iglesias, Ángeles; Ampuero, J.; Granados, R.; Pascasio, J.M.; Rubín, A.; Salmerón, J.; Badia, E.; Planas, J.M.M.; Lens, S.; Turnes, J.; Montero, J.L.; Buti, M.; Esteban, R.; Fernández-Rodríguez, C.M. (Wiley, 2016-11-09)[Abstract] Patients with HCV genotype 3 (GT3) infection and cirrhosis are currently the most difficult to cure. We report our experience with sofosbuvir+daclatasvir (SOF+DCV) or sofosbuvir/ledipasvir (SOF/LDV), with or ... -
Efficacy and safety of HCV-treatment with direct-acting antiviral agents interferon-free, in patients with severe renal impairment in clinical practice
Cabezas, Joaquín; Londoño, M.C.; Llerena, S.; Muñoz, R.; Baliellas, C.; Buti, M.; Pascasio, J.M.; Sáez-Royuela, F.; García-Samaniego, J.; Vega, J. de la; Sánchez-Pobre, P.; Álvarez-Navascues, C.; Carrión, J.A.; Gea, F.; Morillas, R.M.; Fernández-Bermejo, M.; Castro-Iglesias, Ángeles; Rivero, M.; Fernández, J.R.; Berenguer, M.; Moreno, J.J.; Rincón, D.; Calleja, J.L.; Crespo, J. (Elsevier, 2016) -
High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C Registry
Aranda, E.B.; Mariño, Zoe; Calvo, S.; Carrión, J.A.; Fernández, I.; García-Samaniego, J.; Baliellas, C.; Pascasio, J.M.; Albillos, A.; Carrillo, C.F.; Castro-Iglesias, Ángeles; Planas, J.M.M.; Giner, C.P.; Palomares, J.J.M.; Llaneras, J.; Arenas, J.; Fernández-Bermejo, M.; Fernández, C.; López, R.M.G.; García, P.B.; Romero-Gómez, Manuel; Sáez-Royuela, F. (Elsevier, 2017) -
Safety and Efficacy of Sofosbuvir plus Simeprevir in a Spanish Cohort of 622 Cirrhotic Patients Infected with Genotypes 1 or 4
Mariño, Zoe; Pascasio-Acevedo, Juan M.; Sánchez-Antolín, Gloria; Baliellas, C.; Prieto, M.; Moreno, J.M.; Carrión, J.A.; Fernández, I.; Gómez, A.; Montero, J.L.; Castro-Iglesias, Ángeles; Pascual, Sonia; Cabezas, Joaquín; Arencibia, Ana C.; Calleja, J.L.; Sánchez Ruano, Juan José; Castells, Lluis; Albillos, A.; Romero-Gómez, Manuel; García-Samaniego, J.; Narváez, Isidro; Serrano, T.; Giráldez, Álvaro; Xiol, X.; Hontagas, V.; Cuervas-Mons Martínez, Valentín; Crespo, J.; Forns, Xavier (Elsevier, 2016) -
Sofosbuvir/ledipasvir plus ribavirin achieves high SVR12 in genotype‐3 patients with compensated cirrhosis and similar to sofosbuvir plus daclatasvir: a multicentre real life cohort
Riveiro-Barciela, M.; Alonso, Sonia; Fernández, Inmaculada; Rincón, Diego; Real, Yolanda; Crespo, Javier; Gea, Francisco; Olveira, Antonio; Calleja, J.L.; Polo-Lorduy, B.; Carrión, J.A.; Arenas, J.; Devesa, M.J.; Baliellas, C.; Castro-Iglesias, Ángeles; Romero-Gómez, Manuel; Granados, R.; Pascasio, J.M.; Forns, Xavier; Turnes, Juan; Montero, J.L.; Esteban, R.; Fernández-Rodríguez, Conrado M. (Wiley, 2016-10)